PLASMAIRTM High Efficiency Air Treatment Units

Mobile unit with HEPA-MD technology for hospital high risk areas

Over time, PLASMAIRTM Guardian and PLASMAIR Sentinel have become the references for air treatment in operating theatres, hematology departments, bone marrow transplants units and generally in all types of departments receiving high risk patients. The HEPA-MDTM technology combines HEPA filtration quality and microbial destruction (MD) technology using cold plasma, without releasing any toxic compounds. This ensures the highest level of air quality and patient safety.


HEPA MD technology Benefits

  • Improve mechanical filtration efficiency with the addition of an electrostatic effect
  • Inactivates microorganisms through oxidation
  • Reduces particle load in the room
  • No accumulation of viable microbiology in HEPA filters
  • No release of toxic compounds
  • Reduces unpleasant odours

Find out more on the HEPA MDTM Technology


PLASMAIRĀ® Treatment Unit

In hematology, oncology, transplant and cell therapy departments, patients go through a period of aplasia or severe immunosuppression during which they are subject to very special attention to protect them from contamination risks that may prove to be serious or even lethal.

Fungal risk is the main concern of hematology departments where its incidence varies from 4 to 26% with a mortality rate that can reach 92%1. Providing optimum air quality is a mandatory prevention measure.

The ASBMT (The American Society of Blood & Marrow Transplantation 2009) note in their recommendations recourse to mobile air treatment units to protect patients having undergone cell therapy.

PLASMAIRTM units connect to the IMMUNAIRTM and BIOCAIRTM chambers to create an isolated environment for immunocompromised patients as well as highly infectious patients.


1Denning DW. Invasive aspergillosis. Clin Infect Dis 1998 ;26 :781-805
Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005;18:44-69
Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999;12:310-350



Bottom image